Some “Best of ASCO” reports from UroToday

The UroToday web site has now posted a number of “Best of ASCO” reports that might be of interest to some of our readers. … READ MORE …

ASCO abstracts now available on line

The American Society for Clinical Oncology (ASCO) just released the abstracts for the hundreds of presentations and posters that will be given at the upcoming annual meeting of ASCO in June in Chicago. … READ MORE …

ASCO issues new PCO in treatment of chemotherapy-naive CRPC

ASCO has just released a new set of provisional guidance (a “provisional clinical opinion” or PCO) on the second-line treatment of men with chemotherapy-naive, castration-resistant prostate cancer (CRPC), i.e., men who are progressing on initial androgen deprivation therapy (ADT or “hormone” therapy) but who haven’t had docetaxel-based chemotherapy yet. … READ MORE …

Revised ASCO/CCO brachytherapy guidelines

The publication of the ASCENDE-RT clinical trial (discussed here) has led to a revision in the brachytherapy guidelines (available here) issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). The guidelines are for patients who choose radical therapy rather than active surveillance. … READ MORE …

This year’s crop of ASCO abstracts now available on line

Before we have even made it to the annual meeting of the American Urological Association (AUA, starting in New Orleans tomorrow), the abstracts for the annual meeting of the American Society for Clinical Oncology (ASCO, starting in Chicago in another couple of weeks) have now been made available. … READ MORE …

Obesity and cancer (prostate cancer included): new ASCO policy statement

The American Society of Clinical Oncology (ASCO) has just published its first-ever policy statement on obesity and cancer, and is warning that “obesity could soon become the leading cause of cancer” here in America. … READ MORE …

What’s being presented at ASCO this year: I

So here are some links to some initial key papers to be presented at ASCO this year. These four papers all address important issues affecting the treatment of metastatic and later stages of prostate cancer. … READ MORE …